Two Sigma Investments »

Seelos Therapeutics Ord shares owned by Two Sigma Investments

Quarter-by-quarter ownership of Seelos Therapeutics Ord (SEEL) shares owned by Two Sigma Investments from 13F filings

Historical chart of Two Sigma Investments investment in Seelos Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Seelos Therapeutics Ord held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seelos Therapeutics Ord by Two Sigma Investments

Quarter filed Position value Share count Share price at filing
2023-12-31 $35k 25k 1.39

More positions owned by Two Sigma Investments

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Rivian Automotive Com Cl A Put Option (RIVN)
Carnival Corp Unit 99/99/9999 (CCL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Micron Technology (MU)
Netflix (NFLX)
Apple (AAPL)
Visa Com Cl A (V)
Paypal Holdings (PYPL)
Pinterest Cl A (PINS)
Alphabet Cap Stk Cl A (GOOGL)
American Airls Put Option (AAL)
Bristol Myers Squibb (BMY)

View all positions for Two Sigma Investments

Top funds holding Seelos Therapeutics Ord

Wealth Effects
Vanguard Group
Balyasny Asset Management
Jeffrey L. Gendell
Modera Wealth Management
Citadel Advisors
Lynwood Capital Management
Strategic Family Wealth Counselors
Two Sigma Investments
CRA Financial Services
Wealth Enhancement Advisory Services
Advisor Group Holdings
Carmichael Hill & Associates
Bank of America Corporation
Jpmorgan Chase & Co

View all funds holding Seelos Therapeutics Ord